This infused medicine is used in adult patients with moderately to severe Crohn’s disease and ulcerative colitis (UC) when they have not tolerated or responded well to other medicines.
ENTYVIO may help reduce symptoms, induce and maintain remission, heal intestinal lining, or let patients reduce or stop the use of corticosteroids.
ENTYVIO works by focusing on the GI tract, blocking the movement of gut-located white blood cells, which helps control inflammation. It is administered by MIC through a 30-minute infusion every 8 weeks, which is then monitored by our physicians and pharmacists for response, reactions, and effectiveness.
Manufacturer rebates may be available. See http://www.entyvio.com for co-pay assistance support through Entyvio Connect.
CALL 877.448.3627 FOR MORE INFORMATION OR TO SCHEDULE AN APPOINTMENT.